Jump to main content
Jump to site search

Issue 5, 2015
Previous Article Next Article

A low toxic synthetic dendrimer conjugated podophyllotoxin nanodevice with potent antitumor activity against the DMBA/TPA induced mouse skin carcinogenesis model

Author affiliations

Abstract

Natural podophyllotoxin (PODO) is an anticancer drug that functions as an anti-mitotic agent and inhibits tubulin polymerization. However, high toxicity and low bioavailability limit its anticancer applications. To minimize toxicity and enhance solubility under physiological conditions, we conjugated PODO to a poly(amidoamine) (PAMAM) dendrimer to generate sustained-release nanodevices (D-PODO). Free PODO and its dendrimer conjugates were screened for toxicity in Swiss albino mice, and the dose-dependent antitumor activity of D-PODO was evaluated in a two-stage mouse skin carcinogenesis model. The results showed that 8 mg kg−1 D-PODO was nontoxic, whereas the same dose of PODO was highly toxic, as indicated by mortality, biochemical and histopathological studies. An antitumor therapeutic study using D-PODO in tumor-bearing mice revealed a 50–60% inhibition of skin tumor formation. Histopathology and immunohistochemistry studies revealed that D-PODO treatment reduced epithelial hyperplasia, and induced apoptosis by increasing the Bax to Bcl-2 ratio and reducing NF-κB expression. Importantly, the D-PODO conjugate was less toxic than PODO, and inhibited skin tumor progression effectively.

Graphical abstract: A low toxic synthetic dendrimer conjugated podophyllotoxin nanodevice with potent antitumor activity against the DMBA/TPA induced mouse skin carcinogenesis model

Back to tab navigation

Supplementary files

Publication details

The article was received on 14 Apr 2015, accepted on 01 Jun 2015 and first published on 02 Jun 2015


Article type: Paper
DOI: 10.1039/C5TX00112A
Toxicol. Res., 2015,4, 1204-1213

  •   Request permissions

    A low toxic synthetic dendrimer conjugated podophyllotoxin nanodevice with potent antitumor activity against the DMBA/TPA induced mouse skin carcinogenesis model

    U. H. Sk, V. Patial and S. Sharma, Toxicol. Res., 2015, 4, 1204
    DOI: 10.1039/C5TX00112A

Search articles by author

Spotlight

Advertisements